CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR ‐665‐dependent regulation of EGFR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR ‐665‐dependent regulation of EGFR

Published:2021-05-27 Issue:8 Volume:82 Page:1193-1205
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Dong Mingqiang¹,Li Peng²,Xie Yuquan¹,Wang Zhihua³,Wang Rui¹^ORCID

Affiliation:

1. Department of Oncology The First People's Hospital of Jingmen Affiliated to Hubei Minzu University Jingmen Hubei China

2. Department of Emergency The First People's Hospital of Jingmen Affiliated to Hubei Minzu University Jingmen Hubei China

3. Department of Clinical Laboratory Maternal and Child Health Care Hospital of Jingmen Jingmen Hubei China

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21834

Reference31 articles.

1. CircABCC2 Regulates Hepatocellular Cancer Progression by Decoying MiR-665

3. Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR‐150‐5p

4. Integrated genomic and molecular characterization of cervical cancer

5. DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircRNA_0044556 affects the sensitivity of triple-negative breast cancer cells to paclitaxel by regulating miR-665;Journal of Chemotherapy;2024-06-07

2. Promising predictive molecular biomarkers for cervical cancer (Review);International Journal of Molecular Medicine;2024-04-04

3. Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression;Aging;2024-01-19

4. CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression;Oncology Research;2024

5. Splicing-associated chemotherapy resistance in cervical cancer: Targeting splicing signatures;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3